Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-10-03
1998-12-01
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3144
Patent
active
058439382
ABSTRACT:
The use of a compound of the formula: ##STR1## in which X is --O-- or --NH--, or a pharmaceutically-acceptable acid addition salt thereof, in the treatment of atherosclerosis.
REFERENCES:
patent: 4935414 (1990-06-01), Stenzel et al.
patent: 5145849 (1992-09-01), Stenzel et al.
D. Baumgart et al., "Characterization of the inotropic ad arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain," Basic Research in Cardiology, 89 (1), 61-79 (1994).
Dr. Siegfried Klumpp et al., Neues aus Pharmakologie und Toxikologie, Krankenhauspharmazie, 11 (7), 298-299 (1990).
CA: 115:183093 Stenzel et al., 1991.
Mest Hans-Juergen
Stenzel Wolfgang
Beiersdorf-Lilly GmbH
Benjamin Roger S.
Boone David E.
Criares Theodore J.
Leeds James P.
LandOfFree
Treatment of atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395779